Mylan Recalls Ciprofloxacin Tablets Due to Manufacturing Deviations
Mylan Pharmaceuticals is recalling 521 bottles of Ciprofloxacin 250 mg tablets because they were not manufactured according to Good Manufacturing Practices.
- Product
- Ciprofloxacin Tablets, USP, 250 mg, 100-count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7097-01
- Category
- Drug
- Distribution
- Distributed nationwide